Answers are grounded in this paper and cite their sources.
An objective assessment of compliance such as returned vials is much more reliable than compliance based on parental or patient based information. Non-compliance with GH treatment is common, and associated with reduced linear growth. Non-compliance should be considered in all patients with apparently suboptimal response to GH treatment.
No takes yet. Share an insight, caveat, or question.
Cutfield et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: